FDAnews
www.fdanews.com/articles/149847-fda-approves-abbott-humira-as-ulcerative-colitis-therapy

FDA Approves Abbott Humira as Ulcerative Colitis Therapy

October 1, 2012
The FDA has approved Abbott’s Humira (adalimumab) for the treatment of adult patients with moderate to severe ulcerative colitis when certain other medicines have not worked well enough.
Pharmaceutical Business Review